Literature DB >> 20537487

[Small bowel adenocarcinoma].

A Zaanan1, P Afchain, N Carrere, T Aparicio.   

Abstract

Small bowel adenocarcinoma is a rare tumor. These tumors are more often sporadic but there is some predisposing disease (Crohn disease, genetic syndrome and rarely celiac disease). Diagnosis is usually performed at an advanced stage because of non-specific nature of clinical manifestations. New methods of radiological and endoscopic exploration of small intestine should allow earlier diagnosis. Surgical resection remains the only potentially curative treatment for non-metastasic tumors. The main prognosis factor is lymph nodes involvement. The role of adjuvant chemotherapy is unclear. For metastatic tumors, 5-fluorouracil and platinum salt combination appears to be the most effective chemotherapy despite of the absence of randomized studies. A national prospective cohort study is currently evaluating the results of chemotherapy (recommended protocol: FOLFOX) as adjuvant and palliative treatment of small bowel adenocarcinoma. Copyright 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20537487     DOI: 10.1016/j.gcb.2010.01.020

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  2 in total

1.  [Primary malignant tumors of the small intestine: clinical and therapeutic aspects of 27 patients].

Authors:  Halima Abahssain; Maha Mokrim; Issam Lalya; Hind M'rabti; Hassan Errihani
Journal:  Pan Afr Med J       Date:  2011-03-03

2.  [Tumors of the small bowel: about 27 cases].

Authors:  Ihsane Mellouki; Khaoula Jellali; Adil Ibrahimi
Journal:  Pan Afr Med J       Date:  2018-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.